PTN

Palatin Technologies

22.52 USD
-0.98
4.17%
At close Updated Mar 16, 4:00 PM EDT
1 day
-4.17%
5 days
5.18%
1 month
28.03%
3 months
-12.41%
6 months
103.99%
Year to date
40.31%
1 year
-44.41%
5 years
-97.63%
10 years
-95.71%
 

About: Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.

Employees: 29

0
Funds holding %
of 8,079 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™